$4.5MSeed, 31 March 2026
Seed to advance drugs against epigenetic targets in deadly pediatric brain cancer
- Amount
- $4.5M
- Stage
- Seed
- Announced
- 31 March 2026
- Lead
- SOSV
- Use of funds
- Seed to advance drugs against epigenetic targets in deadly pediatric brain cancer
- Checked
- Announced by the company
- Source
- TippingPoint Biosciences raises $4.5M seed pulse2.com